Filip Vrbacký - Concepedia

Author

Filip Vrbacký

Also Known As

F Vrbacky, F. VRBACKY, F. Vrbacky, F. Vrbacký, F.F.V. Vrbacky, Filip VRBACKY, Filip Vrbacky, Filip Vrbacký, Vrbacky F, Vrbacky, Filip

Publications

325

Citations

H-Index

Concepts

All Affiliations

Charles University University Hospital Hradec Králové University Hospital Brno Masaryk University Czech Academy of Sciences, Institute of Biophysics

About

Filip Vrbacký is an author at Charles University specializing in hematology, pathology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	70
2	Pathology	3	3	70
3	Hematology	3	3	70
4	Health Sciences	1	1	34
5	Immunology	1	1	13

Filip Vrbacký

Publications

239

Citations

H-Index

Page 1

	Year	Citations
Cervical Microbiota in Women with Preterm Prelabor Rupture of Membranes Marián Kacerovský, Filip Vrbacký, Radka Kutová, PLoS ONE	2015	68
IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring? Lucie Petrová, Filip Vrbacký, Miriam Lánská, Clinical Biochemistry Hematological MalignancyOncologyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute Leukemia	2018	34
Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment Monika Jaruskova, Nikola Čuřík, Rajna Hercog, Journal of Experimental & Clinical Cancer Research	2017	25
Venous thromboembolism in patients with chronic lymphocytic leukemia Martin Šimkovič, Pavel Vodárek, Monika Motyčková, Thrombosis Research ThrombosisVenous DiseaseVenous ThrombosisChronic Lymphocytic LeukemiaHematology	2015	23
<i>COBLL1</i>,<i>LPL</i>and<i>ZAP70</i>expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with<i>IGHV</i>mutational status Hana Plešingerová, Zuzana Librova, Karla Plevová, Leukemia & lymphoma/Leukemia and lymphoma	2016	21
Identification of a four-gene methylation biomarker panel in high-grade serous ovarian carcinoma Ivana Baranová, Helena Kovaříková, Ján Laco, Clinical Chemistry and Laboratory Medicine (CCLM)	2020	18
The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients Petra Bělohlávková, Filip Vrbacký, J Voglová, Archives of Medical Science	2018	17
Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features Filip Vrbacký, Lukáš Smolej, V. Vroblova, Hematology ImmunologyPathologyTumor BiologyHematological MalignancyOncology	2010	13
Significant change in ZAP‐70 expression during the course of chronic lymphocytic leukemia V. Vroblova, Filip Vrbacký, Monika Hrudková, European Journal Of Haematology	2010	10
FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia Laura Ondrišová, Václav Šeda, Krystof Hlavac, Journal of Clinical Investigation	2024	10

Page 1